Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

January 1, 2021
Open Access

Definition of a small core transcriptional circuit regulated by AML1-ETO

Molecular Cell
Kristy R StengelScott W Hiebert
January 21, 2021

Prognostic value of HMGN family expression in acute myeloid leukemia.

Future Oncology
Wei CuiYan Liu
January 22, 2021

AD80, a multikinase inhibitor, exhibits antineoplastic effects in acute leukemia cellular models targeting the PI3K/STMN1 axis.

Investigational New Drugs
Jorge Antonio Elias Godoy CarlosJoão Agostinho Machado-Neto
January 6, 2021
Open Access

Different mutant RUNX1 oncoproteins program alternate haematopoietic differentiation trajectories

Life Science Alliance
Sophie G KellawayConstanze Bonifer
January 13, 2021
Open Access

epihet for intra-tumoral epigenetic heterogeneity analysis and visualization

Scientific Reports
Xiaowen ChenSheng Li
January 12, 2021

Prognostic mutation constellations in acute myeloid leukaemia and myelodysplastic syndrome

Current Opinion in Hematology
Ilaria Iacobucci, Charles G Mullighan
January 22, 2021

LncRNA FBXL19-AS1 is a diagnosis biomarker for paediatric patients with acute myeloid leukemia.

The Journal of Gene Medicine
Hongling ShengRenpeng Jiang
January 13, 2021
Open Access

Clinical and genomic characterization of patients diagnosed with the provisional entity Acute myeloid leukemia with BCR-ABL1, a Swedish population-based study

Genes, Chromosomes & Cancer
Christina Orsmark-PietrasVladimir Lj Lazarevic
January 3, 2021

GATA1 mutation analysis and molecular landscape characterization in acute myeloid leukemia with trisomy 21 in pediatric patients

International Journal of Laboratory Hematology
Agnesa PanferovaYulia Olshanskaya
January 21, 2021
Open Access

Drosophila Hox genes induce melanized pseudo-tumors when misexpressed in hemocytes.

Scientific Reports
Titus PonrathnamRakesh K Mishra
January 4, 2021
Open Access

Studying leukemia stem cell properties and vulnerabilities with human iPSCs

Stem Cell Research
Nikolaos Spyrou, Eirini P Papapetrou
January 9, 2021
Open Access

Expression and role of fibroblast activation protein α in acute myeloid leukemia

Oncology Reports
Shuchong MeiFuming Zi
December 31, 2020
Open Access

Epigenetic changes in human model KMT2A leukemias highlight early events during leukemogenesis

Thomas MilanBrian T Wilhelm
January 4, 2021
Open Access

Phosphoproteomic Landscape of AML Cells Treated with the ATP-Competitive CK2 Inhibitor CX-4945

BioRxiv : the Preprint Server for Biology
M. RosalesSilvio E. Perea

Sign up to follow this feed and discover related papers.

Related Feeds

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Antisense Oligonucleotide Therapies: ND

Antisense oligonucleotides are synthetic DNA oligomers that hybridize to a target RNA. This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

© 2021 Meta ULC. All rights reserved